Author

C.-W. Ke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metagenomics· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

B. Wang· 1 shared B.-x. Ke· 1 shared C. Sun· 1 shared C. Wan· 1 shared C.-g. Jiang· 1 shared C.-p. Lv· 1 shared D.-q. Liu· 1 shared E.-h. Dai· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. Wang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Gene mutations and molecular evolution of the chikungunya virus E1 and E2 from 2014 to 2019

X. Li, X. Li, J. Liu, S. Liang, H. Chen, C.-W. Ke, C. Wan

This study analyzes gene mutations in CHIKV E1 and E2 proteins from 2014 to 2019, identifying common mutation sites and their potential impact on immune escape and serological detection.

bioRxiv · Mar 16, 2022 · PreprintEvolutionary Biology

Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate

Y.-F. Kang, C. Sun, Z. Zhuang, R.-Y. Yuan, Q.-B. Zheng, P.-P. Zhou, J.-P. Li, X.-C. Chen, X. Zhang, X.-H. Yu, X.-W. Kong, Q.-Y. Zhu, M. Xu, N.-S. Zhong, Y.-X. Zeng, , M.-S. Zeng

This study designs and tests RBD-conjugated nanoparticle vaccines against SARS-CoV-2, showing enhanced neutralizing activity compared to monomeric RBD.

bioRxiv · Nov 3, 2020 · PreprintMicrobiology

The immunodominant and neutralization linear epitopes for SARS-CoV-2

S. Lu, X.-x. Xie, L. Zhao, B. Wang, J. Zhu, T.-r. Yang, G.-w. Yang, M. Ji, C.-p. Lv, J. Xue, E.-h. Dai, X.-m. Fu, D.-q. Liu, L. Zhang, S.-j. Hou, , R.-t. Liu

This study identifies immunodominant and neutralizing epitopes on SARS-CoV-2 proteins through computational simulation and experimental validation in mice.

bioRxiv · Aug 27, 2020 · PreprintImmunology